Nostra Terra Oil and Gas Company PLC CEO Paul Welch talked with Proactive's Stephen Gunnion about the company’s strategy to scale up production and drive growth from its existing base of operations in East Texas and West Texas. Welch explained that Nostra Terra is currently focused on the Pine Mills field, a long-life, shallow onshore field with low operating costs and consistent profitability. “It's been an exciting field for the last 75 years and we expect it to be an exciting field for the program for the next 20 to 30 as well,” he said. Since taking over as CEO around nine months ago, Welch has led the company to profitability by cutting costs and increasing production. He highlighted two successful well workover programs that have effectively doubled production. A key highlight is the Fouke area, where new drilling, including the upcoming Fouke-3 well, could deliver significant volumes. Welch pointed out that these wells can initially produce around 120 barrels per day—compared to the average of 6 to 10 barrels from the Pine Mills wells. If enhanced recovery schemes are implemented, the output could potentially double. Welch reaffirmed the company’s ambitious growth target: “This is a company that's going to be making 5,000 barrels a day in the next 3 to 5 years.” The focus remains on building from a solid, profitable base, with production costs in the Fouke area as low as $3 to $4 per barrel, ensuring resilience across various oil price environments. Watch the full interview to hear more on the outlook for 2025, drilling plans, and the strategic path forward. For more interviews like this, visit Proactive’s YouTube channel. Don’t forget to like the video, subscribe to our channel, and enable notifications to stay updated on the latest content. #NostraTerra #OilAndGas #PaulWelch #TexasOil #PineMillsField #FoukeArea #EnergyStocks #OilProduction #InvestorUpdate #ProactiveInvestors

Reconnaissance Energy Africa CEO Brian Reinsborough joined Steve Darling from Proactive to share a drilling update on Prospect I, located onshore Namibia within Petroleum Exploration Licence 073. Prospect I represents the company’s largest exploration target to date. It is estimated to hold approximately 365 million barrels of unrisked and 32 million barrels of risked prospective light to medium oil resources, or alternatively, 1.9 trillion cubic feet of unrisked and 140 billion cubic feet of risked prospective natural gas resources, based on a 100% working interest. Reinsborough reported that pre-construction activities are progressing on schedule and that pre-drill evaluations have been successfully completed. Drilling is planned to reach a target depth of 3,800 metres, with the flexibility to drill deeper depending on subsurface conditions—similar to the company’s approach with the Naingopo exploration well. The Otavi geological section is anticipated to range between 1,500 and 1,800 metres in thickness, depending on total drilling depth. Insights gained from the Naingopo well have significantly enhanced ReconAfrica’s understanding of the Damara Fold Belt, particularly regarding time-depth migration and structural interpretation of the Mulden and Otavi formations. This same reservoir zone at Naingopo exhibited more than 50 metres of reservoir-quality carbonates and oil shows, underscoring its potential. These developments mark an important step in advancing ReconAfrica’s exploration strategy in one of Africa’s most promising onshore hydrocarbon basins. #proactiveinvestors #reconnaissanceenergyafricaltd #tsxv #reco #otcqx #recaf #NamibiaOil #ProspectI #OilExploration #EnergyUpdate #OnshoreDrilling #OilAndGasNews #AfricanEnergy #OilDiscovery #EnergyInvesting

Scancell Holdings PLC CEO Phillip L’Huillier joined Proactive's Stephen Gunnion with details of the company’s partnership with the NHS Cancer Vaccine Launchpad to accelerate patient recruitment for its SCOPE study evaluating the iSCIB1+ DNA cancer vaccine. L’Huillier described the deal as “a very positive endorsement for Scancell and for the medicines that we are developing,” noting that the therapy is showing promise in delivering long-term immune control in advanced melanoma patients. The NHS collaboration enables hospitals to more quickly access and offer the iSCIB1+ therapy as part of the trial, making Scancell the first UK company to partner with the platform and the first to offer a DNA cancer vaccine through it. He explained that the vaccine is given alongside checkpoint inhibitors, currently standard care, to boost response rates and prolong efficacy, especially where standard therapy alone sees limited, short-lived results. L’Huillier confirmed multiple SCOPE study data readouts are expected in 2025, with a larger development phase targeted for 2026. The company is also progressing its Modi-1 peptide vaccine and aims to further develop its GlyMab antibody platform, including the SC134 programme for small cell lung cancer. L’Huillier said his CEO priorities include sticking to development timelines, building strategic partnerships, and preparing the organisation for future phases. For more exclusive biotech interviews, visit Proactive's YouTube channel. Don't forget to like the video, subscribe to the channel, and enable notifications for future updates. #Scancell #CancerVaccine #BiotechNews #iSCIB1 #MelanomaResearch #NHSPartnership #DNAImmunotherapy #Modi1 #ClinicalTrials #OncologyInnovation #InvestorUpdate #ProactiveInvestors

North Bay Resources CEO Jared Lazerson joined Steve Darling from Proactive to share news of the company’s first successful gold concentrate sale from a test shipment processed at the Bishop Gold Mill, using ore from the Fran Gold Project. Lazerson confirmed that final acceptance and settlement have been completed, with all refinery requirements met, and assay comparisons for gold, silver, and moisture content agreed upon. The test concentrate represents approximately 10 tons of gross ore, processed through the gravity-only circuit. Lazerson noted this marks an important milestone in the early phase of operations. The flotation circuit, which is expected to significantly enhance recovery rates, is set to come online this month. The company currently has another test shipment in process and has completed a third concentrate shipment, further validating operational momentum. The most recent sale netted approximately $400 per ton, based solely on gravity recovery. However, with further optimization and the integration of the flotation circuit, recoveries are projected to double, potentially reaching over 90% total recovery. This would raise the value per ton to around $800, significantly improving project economics. North Bay Resources currently has 75 tons of ore stockpiled at the Bishop Gold Mill, which will be processed as part of continued optimization and ramp-up. Additionally, there are approximately 5,000 tons of ore stockpiled at the project site, positioning the company for a steady flow of future shipments as operations scale. The CEO also discussed the reinterpretation of 15 years of historical drilling data—104 holes covering 18,000 metres—which has revealed the potential for a bulk tonnage deposit. This reinterpretation aligns with nearby major low-grade, high-volume gold projects like Mount Milligan and Blackwater. #proactiveinvestors #northbayresourcesinc #otc #nbri #PlatinumConcentrate #NorthBayResources #MiningNews #CaliforniaGold #JaredLazerson #G